FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that Dr. Charles E. Hart, chief scientific officer, will provide an update of corporate activities at the Deutsche Bank 32nd Annual Health Care Conference. The presentation will take place at the Mayflower Hotel in Washington D.C. on Thursday, May 3 at 2:30 p.m. Eastern Time.
